Abstract
Native fish-eye disease plasma, which is deficient of both high density lipoproteins (HDL) and lecithin-cholesterol acyltransferase activity (α-LCAT), processing the free cholesterol of these lipoproteins, has been supplemented with normal isolated HDL2 or HDL3 and incubated in vitro at 37 C. After incubation for 0,7.5 and 24 hr the very low density (VLDL) and low density (LDL) lipoproteins as well as HDL were isolated, and their contents of triglycerides, phospholipids and free, esterified and total cholesterol were quantified. The resulting net mass transfer of the different lipids revealed a functioning transfer of cholesteryl esters and all other analyzed lipids between the lipoproteins, although no de novo esterification of the HDL cholesterol by LCAT in this plasma occurred. In accordance with previous findings there was a functioning esterification process of the free cholesterol of the combined VLDL and LDL of fish-eye disease plasma. The present results make it reasonable to conclude that the lack of HDL cholesterol esterification in this disease is not a result of a deficiency of cholesteryl ester transfer or lipid transfer activities.
Similar content being viewed by others
References
Carlson, L.A., and Philipson, B. (1979)Lancet 2, 921–923
Carlson, L.A. (1982)Eur. J. Clin. Invest. 12, 41–53.
Carlson, L.A., and Holmquist, L. (1985)Acta Med. Scand. 218, 189–196.
Carlson, L.A., and Holmquist, L. (1985)Acta Med. Scand. 218, 197–205.
Fielding, P.E., Fielding, C.J. (1980)Proc. Natl. Acad. Sci. 77, 3327–3330.
Calvert, G.D., and Carlson, L.A. (1983)Acta Med. Scand. 213, 253–254.
Carlson, L.A., and Holmquist, L. (1983)Acta Med. Scand. 213, 177–182.
Carlson, L.A. (1963)J. Atheroscler. Res. 3, 334–336.
Fletcher, M.J. (1968)Clin. Chim. Acta 22, 393–397.
Bartlett, G.R. (1959)J. Biol. Chem. 234, 466–468.
De Lalla, O.F., Elliot, H.A., and Gofman, J.W. (1954)Am. J. Physiol. 179, 333–337.
Carlson, K. (1973)J. Clin. Pathol. (suppl)5, 32–37.
Nichols, A.V., and Smith, L. (1965)J. Lipid Res. 6, 206–210.
Marcel, Y.L. (1982)Adv. Lipid Res. 19, 85–136.
Norum, K.R., Berg, T., Helgerud, P., and Drevon, C.A. (1983)Physiol. Rev. 63, 1343–1419.
Barter, P.J. (1984) inClinical and Metabolic Aspects of High-Density Lipoproteins (Miller, N.E., and Miller, G.J., eds.) pp. 160–185, Elsevier Science Publishers B.V., Amsterdam, New York, Oxford.
Norum, K. (1984) inTreatment of Hyperlipoproteinemia (Carlson, L.A., and Olsson, A.G., eds.) pp. 69–75, Raven Press, New York.
Glomset, J.A., Jansen, E.T., Kennedy, R., and Dobbins, J. (1966)J. Lipid Res. 7, 639–648.
Marshall, T., Williams, K.M., Holmquist, L., Carlson, L.A., and Vesterberg, O. (1985)Clin. Chem. 31, 2032–2035.
Deckelbaum, R.J., Olivecrona, T., and Eisenberg, S. (1984) inTreatment of Hyperlipoproteinemia (Carlson, L.A., and Olsson, A.G., eds.) pp. 85–93, Raven Press, New York.
Fielding, P.E., Fielding, C.J., and Havel, R.J. (1983)J. Clin. Invest. 71, 449–460.
Carlson, L.A., and Holmquist, L. (1983)Atherosclerosis 47, 305–306.
Nichols, A.V., Gong, E.L., and Blanche, J. (1981)Biochem. Biophys. Res. Commun. 100, 391–399.
Holmquist, L., and Carlson, L.A. (1987)Acta Med. Scand. 221, 283–289.
Author information
Authors and Affiliations
About this article
Cite this article
Holmquist, L., Carlson, L.A. Net lipid transfer between lipoproteins in fish-eye disease plasma supplemented with normal high density lipoproteins. Lipids 22, 305–311 (1987). https://doi.org/10.1007/BF02533997
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02533997